Instrumento Inactivo

Otros idiomas GEMI THER

Acciones

GMTX

US36870G1058

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Arix portfolio firm Disc Medicine seals Gemini Therapeutics merger	30/12/22
DISC MEDICINE, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Amendment or Waiver to Code of Ethics, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	29/12/22
Gemini Therapeutics, Inc.(NasdaqGM:GMTX) dropped from NASDAQ Composite Index	29/12/22
Disc Medicine, Inc. completed the acquisition of Gemini Therapeutics, Inc. for approximately $200 million in a reverse merger transaction.	29/12/22
GEMINI THERAPEUTICS, INC. /DE : Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)	28/12/22
Gemini Therapeutics Shares Rise After Disc Medicine Gets FDA Designation	27/12/22
GEMINI THERAPEUTICS, INC. /DE : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	27/12/22
Gemini Therapeutics' Disc Medicine Secures FDA's Orphan Drug Status for Erythropoietic Protoporphyria Treatment	22/12/22
Disc Medicine Announces Several Presentations Across Hematology Portfolio at the 64th American Society of Hematology Annual Meeting	14/12/22
GEMINI THERAPEUTICS, INC. /DE : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	13/12/22
GEMINI THERAPEUTICS, INC. /DE : Change in Directors or Principal Officers (form 8-K)	08/12/22
GEMINI THERAPEUTICS, INC. /DE Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	10/11/22
Gemini Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/11/22
GEMINI THERAPEUTICS, INC. /DE : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	31/10/22
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCKT, RCOR, EVOP, GMTX	20/09/22
Gemini Therapeutics, Inc.(NasdaqGM:GMTX) dropped from S&P Global BMI Index	19/09/22
GEMINI THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Gemini Therapeutics, Inc. - GMTX	13/08/22
SHAREHOLDER ALERT: Weiss Law Investigates Gemini Therapeutics, Inc.	11/08/22
GEMINI THERAPEUTICS, INC. /DE Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	11/08/22
Gemini Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/08/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas GEMI THER

Acciones

GMTX

US36870G1058

Otros idiomas

Filtros